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a b s t r a c t
Detection and characterisation of the canine parvovirus (CPV-2) strains that are currently circulating are
essential for the understanding of viral evolution and the development of measures to control its spread.
In the present study, stool samples from 144 dogs were analysed by polymerase chain reaction (PCR) for
CPV-2, and 29.2% (42/144) of them were positive. From the 42 positive strains, 71.4% (30) of the dogs
had signs of haemorrhagic gastroenteritis. The sequencing of the 583bp fragment of the VP2 gene from
the positive strains identiﬁed 78.6% (33/42) of them as type 2c, 19% (8/42) as type 2b and 2.4% (1/42) aseywords:
anine parvovirus
PV-2
etection
haracterisation
type 2a. A phylogenetic analysis of the variants circulating in the canine population of Brazil showed that
they are very similar to those found in other countries and type 2c has become the predominant type
circulating in Brazil.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.hylogeny
. Introduction
Treatment of gastrointestinal diseases comprises a large part
f small animal medicine, in which typical clinical signs are vom-
ting and diarrhoea that can lead to death of the animal (Sellon,
005). Among the main viruses that cause diarrhea are the canine
arvovirus-2 (CPV-2), canine enteric coronavirus (CCoV), canine
otavirus (CRV) and canine distemper virus (CDV) (Hoskins, 1997;
ams, 2003). Since the late 1970s, the CPV-2 strain has been known
o be a major etiologic agent of infectious gastroenteritis in young
ogs (Appel et al., 1979; Morais and Costa, 2007). Thus, canine par-
ovirus, which occurs with high frequency and endures for long
eriods of time in the environment, has stood out among other
iseases because it results in high rates of morbidity and mor-
ality (Hoskins, 1997). CPV-2 was ﬁrst isolated in 1978, and since
hen, it has given rise to new antigenic types that have spread in
he dog population (Appel et al., 1979; Morais and Costa, 2007).
ver time, the original CPV-2 has been replaced by its antigenic
ariants, CPV-2a and CPV-2b (Decaro et al., 2008). A strain with
n amino acid change, (Asp) – 426 to (Glu) – 426, in an impor-
ant antigenic site was recognised in Italy in 2000 and was named
∗ Corresponding author at: Av. Bento Gonc¸alves 9090, Agronomia, Porto Alegre,
io Grande do Sul, CEP 91.540-000, Brazil. Tel.: +55 51 33086926;
ax: +55 51 33087325.
E-mail address: claudio.canal@ufrgs.br (C.W. Canal).
168-1702/© 2012 Elsevier B.V. Open access under the Elsevier OA license. 
oi:10.1016/j.virusres.2012.01.001CPV-2c (Buonavoglia et al., 2001). Subsequently, this strain was
identiﬁed in Vietnam (Nakamura et al., 2004) and Spain (Decaro
et al., 2006). In South America, this new type was ﬁrst reported in
Uruguay (Pérez et al., 2007), followed by Brazil (Streck et al., 2009)
and Argentina (Calderón et al., 2009). The identiﬁcation and moni-
toring of the types of CPV-2 circulating in the canine population are
important in the understanding of viral evolution and the develop-
ment of measures to control its spread. The present study aimed to
detect the presence and characterise the types of CPV-2 circulating
in Brazil between the years 2008 and 2010.
2. Materials and methods
2.1. Samples
The analysis was performed on 144 samples of dog faeces col-
lected in 20 districts of six Brazilian states from April 2008 to July
2010. These animals,whichwere agedbetween1monthand1year,
included animals with or without symptoms of haemorrhagic gas-
troenteritis (HGE), animals with or without a vaccination history
and animals from different breeds and both genders.2.2. DNA extraction
The stool samples were diluted to 20% (w/v) in phosphate
buffered saline (PBS, pH 7.4). The solution was frozen and thawed
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hree times and then centrifuged at 1500× g for 10min. DNA
as extracted from the supernatant using a commercial kit based
n guanidine isothiocyanate and silica (Biotechnology Simbios,
anoas-RS, Brazil) as described by Boom et al. (1990) and stored
t −20 ◦C until use. A commercial vaccine was used as a positive
ontrol and distilled water was used as a negative control.
.3. Polymerase chain reaction (PCR)
We ampliﬁed 583bp of the VP2 gene (position 4003–4585)
sing the protocol described by Buonavoglia et al. (2001). The PCR
roductswere electrophoresed in 2% agarose gels, visualised under
V light and comparedwith a 100bpmolecularweight ladder (Fer-
entas, USA).
.4. Sequencing of the ampliﬁcation products
The ampliﬁcation products were puriﬁed using GFX PCR
NA and gel band puriﬁcation (Amersham Bioscience, USA)
nd sequenced by using the Abi-Prism 3100 Genetic Analyzer
Applied Biosystems, USA). The alignment and analysis were inter-
reted using the Clustal method with the BioEdit 7.0.0 software
http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The sequences
ere submitted to GenBank (http://www.ncbi.nlm.nih.gov) and
he accession numbers are shown in Table 1.
.5. Phylogenetic analysis
For the phylogenetic analysis, 28 CPV-2 sequences from 14
ountries were retrieved from GenBank. Two Brazilian sequences
DQ340434 and DQ340409) (Pereira et al., 2000) and a sequence of
elinepanleukopeniavirus (AB054225), representing theout group,
ere also included. The Bayesian inference (BI) of phylogeny was
erformed using MrBayes 3.1.2 (Huelsenbeck and Ronquist, 2001).
he substitution model for BI analyses was found using MrMODEL-
EST (Nylander, 2002) with the AIC criterion. Four Markov chains,
ne cold and three heated, were run for 2×106 generations, trees
ere strained every 100 generations and those generated prior to
tationary were discarded as “burn-in”. The posterior probability
alues for all clades in the ﬁnal majority rule consensus tree are
eported. The support values shownalongeachbranchareBayesian
osterior probabilities (Nodal support values <50% not shown).
Samples were assigned to one CPV-2 type based in the presence
f a deduced asparagine (2a), aspartic acid (2b) or a glutamic acid
2c) in the amino acid position 426 (Buonavoglia et al., 2000).
. Results
Of the 144 stool samples analysed by PCR, 29.2% (42/144) were
ositive for CPV-2 (Table 1). Ampliﬁcation of the partial VP2 gene
isplayedasinglebandwith theexpected583bp.Of thedogsexam-
ned, 38.8% had haemorrhagic gastroenteritis (HGE), but from the
2 positive samples, 71.4% displayed signs of HGE (Table 2). From
io Grande do Sul, 111 samples were analysed, which were from
he municipalities of Porto Alegre, Viamão, Cachoeirinha, Taquara,
anoas, Caxias do Sul, Passo Fundo, Bagé, Glorinha, Gravataí, San-
ana do Livramento, Lavras do Sul, Novo Hamburgo, Rio Pardo and
ão Francisco de Paula. The states of Santa Catarina (SC), Paraná
PR), São Paulo (SP), Rio de Janeiro (RJ) and Rondônia (RO) had a
otal of 33 samples that resulted in nine CPV-2-positive samples.
equencing the ampliﬁcation product from the 42 positive samples
llowed us to identify nucleotide mutations, although the majority
ere silent (Table 1). It was possible to identify 78.6% (33/42) of
he samples as type 2c, 19% (8/42) as type 2b and 2.4% (1/42) as
ype 2a. From the positive animals, 33.3% (14/42) were aged less
han 2 months, 47.6% (20/42) had no vaccination history and the 6rch 165 (2012) 29–33
animals with a complete immunisation schedule were positive for
CPV-2c. Regarding breed, 11 mixed breeds, 6 German Shepherds
and 3 Rottweilers were CPV-2c positive and their ages ranged from
2 to 10 months.
In general, the BI and NJ trees (not shown here) were different
because many possible topological resolutions were found, with
weak support. Salient features of all trees included that (a) CPV-2
Brazilian variants can be considered to be cosmopolitan, with sim-
ilar variants in South America, Europe, Africa and Asia and (b) no
clear geographic structure was found showing that CPV-2 variants
are widely dispersed along the studied area. The BI tree (Fig. 1)
showed that the CPV-2 Brazilian variants have clustered into dif-
ferent groups.
4. Discussion
Since its emergence in the late 1970s, parvovirus has caused
high rates of morbidity and mortality, but the severity was initially
attributed to a lack of natural immunity in the canine population
against the virus. Therefore, dog vaccination and natural exposure
to infection shouldhave improvedprotection; however, a high inci-
dence of disease continues in animals aged between 6 weeks and
6 months (Morais and Costa, 2007). This trend was conﬁrmed by
data found in the present study, in which 95.2% of the positive
animals were between 1 and 6 months of age. Puppies are more
prone to the development of haemorrhagic gastroenteritis caused
byCPV-2, althoughdogsof any age, gender or breedmaybeaffected
(McCandlish, 1999; Morais and Costa, 2007; Parrish, 1999). From
the 42 positive animals detected in the present study, 12 displayed
no signs of HGE, showing that the clinical outcome may depend
on the degree of maternal immunity, virulence of the virus strain,
infectious virus dose and the host’s immune system (Homem et al.,
1999; Sellon, 2005; Tams, 2003).
It should be noted that in Brazil, canine parvovirus vaccines
consist of live attenuated virus (CPV-2 and CPV-2b) and which,
although it is rare, may be detected in the faeces of dogs (Decaro
et al., 2007). However, the sequencing analyses of the CPV-2b
described in the current study demonstrated that a point mutation
at residue position 570 (A–G), which is characteristic of the CPV-2b
vaccine strain,was not observed in the present sequences, conﬁrm-
ing that theCPV-2bstrainsdetectedwerenot related tovaccination.
These data corroborate previous reports that have demonstrated
the high stability of the virulence attenuation of the strains used in
current vaccines (Decaro et al., 2006).
German Shepherds and Rottweilers were among the breeds of
dogs that were CPV positive. These two breeds, as well as other
medium and large breeds, are more susceptible and can develop
a more severe clinical picture when infected by CPV (Morais and
Costa, 2007; Sellon, 2005). Interestingly, the six animals that had
received a complete vaccination protocolwere infected by the vari-
ant CPV-2c and displayed HGE, which resulted in death for one
of them. These data corroborate previous ﬁndings in the United
States and Uruguay (Kapil et al., 2007; Pérez et al., 2007), although
it had been shown that vaccination would protect dogs exposed to
CPV-2c (Spibey et al., 2008). However, in ﬁeld situations, the vacci-
nation protocol and maternal antibody titers are variable and may
inﬂuence the appropriate response to the vaccine (Sellon, 2005).
The Brazilian CPV-2a strain contained the amino acid valine at
position555ofVP2,whichhasbeendescribedbyPérez et al. (2007).
In the 1980s, CPV-2a strains from many countries displayed the
amino acid valine in this position (Cavalli et al., 2008; Decaro et al.,
2006). The Ile555Val change can be considered to be a reversion
to the original CPV-2 (Martella et al., 2006; Pereira et al., 2007).
Comparison of the CPV-2c strains from Europe and Uruguay with
those found in Brazil revealed silent mutations in residue 461 (AG)
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Table 1
Characteristics of the CPV-2 positive dogs in different locations in Brazil, describing the main differences in some nucleotides and amino acids.
Accession no. Breed Gender Age Vaccin. program CPV-2 type Position of the codon and amino acid
426 431 440 461 546 547 555 573
FJ222821/VP2 56/00 – – – 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
EF375479 Uruguay ST NA NA V 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
DQ340409 NA NA NA NA 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
DQ340434 NA NA NA NA 2a AAT(Asn) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
EU797726 Mo M 5m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
EU797727 GS F 4m V 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
EU797728 Mo F NA NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
FJ236063 GS F 3m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
FJ236064 P F 2m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
FJ236065 NA NA 2m NA 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
FJ236066 NA NA 2m NA 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
FJ236067 NA NA 6m NA 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
FJ236068 NA F NA NA 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796211 D M 2m NV 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796210 Mo M 12m NV 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796208 GS M 2m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796209 GS F 2m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
GQ395692 R M 3m V 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
GQ452297 Mo F 3m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796207 S F 2m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) ACA(Thr) GTA(Val) TTT(Phe)
JF796206 BI M 2m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) ACA(Thr) GTA(Val) TTT(Phe)
JF796205 A M 4m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796204 Mo M 5m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796203 Mo M 3m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796202 Mo F 3m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796201 R M 4m NV 2c GAA(Glu) GTA(Val) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796200 Mo M 4m NV 2a AAT(Asn) CTA(Leu) ACA(Thr) CCG(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796199 GS M 4m NV 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796198 R M 6m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796197 Mo M 3m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796196 Mo F 4m V 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796195 Mo F 5m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796194 LR M 4m V 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796193 Mo M 4m V 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796192 P F 2m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796191 GS M 2m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796190 D M 2m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796189 Mo F 2m NV 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796188 Y M 4m V 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796187 Mo M 10m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796186 P M 6m V(I) 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796185 GR M 1m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAC(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796184 S F 3m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796183 Mo M 2m NV 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796182 GS M 2m V(I) 2c GAA(Glu) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
JF796181 Mo F 4m NV 2b GAT(Asp) CTA(Leu) ACA(Thr) CCA(Pro) AAT(Asn) CCA(Pro) GTA(Val) TAT(Tyr)
F: female; M: male; m: month; Mo: Mongrel; GS: German Shepherd; GR: Golden Retriever; P: Pinscher; Y: Yorkshire; LR: Labrador Retriever; R: Rottweiler; A: Akita; D: Dachshund; BI: English Bulldog; Sch: Schnauzer; S: Shi-tzu;
ST: Short Terrier; NA: not available; NV: not vaccinated; V(I): incomplete vaccination; V: vaccinated. In bold are the mutations found in the CPV-2 Brazilian sequences.
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AB054225 FPV
AF306447  Italy 2a
AY742935 Germany 2a
AY742933  New Zeland 2a
EF375482 Uruguay 2a
HQ589341 Argentina 2a
DQ340434 Brazil 2a
JF796200 BR 2a •
U72698 Taiwan 2a
EU483516 China 2a
FJ197835 South Korea 2a
AY742953 USA 2a
DQ182620 India 2a
AB128923 Japan 2b
EU483517 China 2b
FJ236067 BR 2b • (5) 
HQ589342 Argentina 2b
AY742941 Germany 2b
DQ340409 Brazil 2b
AF306449 Italy 2b
AY742947 USA 2b
DQ182623 India 2b
96186 2
67
JF7  BR b • 
EF599097 South Korea 2b
JF796210 BR 2b • 
AJ007498 South Africa 2b
U72696 Taiwan 2b
AB120727 Vientam 2c
AB120727 Japan 2c
JF796192 BR 2c • (4) 
HQ445621 Argentina 2c
JF796207 BR 2c •  
JF796206 BR 2c •  
AY380577 Germany 2c
EU797726 BR 2c • (6) 
JF796201 BR 2c •  
GQ452297 BR 2c • (4) 
GQ865519 Greece 2c
EF375481 Uruguay 2c
JF796195 BR 2c • (9)  
FJ222821 Italy 2c
EF375479 Uruguay 2c
54
100
100
70
0.01
Fig. 1. Nucleotide phylogenetic tree based on theVP2 gene of CPV-2 strains circulating in Brazil between the years 2008 and 2010 ()with 28 otherworldwide CPV-2 variants.
Principal bootstrap values are indicated. The values in parentheses indicate the number of strainswith identical sequences to that included in the tree. (5): FJ236068, JF796199,
JF796181, JF796189, JF796211; (4): JF796190, JF796193, JF796203, JF796198; (6): EU7977
JF796196, JF796184; (9): JF796204, JF796182, JF796202, JF796191, JF796205, JF796183, JF
Table 2
Results of the analysis by PCR for CPV-2 from stool samples of dogswith andwithout
haemorrhagic gastroenteritis (HGE).
Positive by PCR Negative by PCR Total
Dogs with HGE 30 26 56
Dogs without HGE 12 76 88
Total 42 102 14428, JF796209, FJ236065, EU797727, FJ236066, FJ236063; (4): JF796197, GQ395692,
796194, JF796188, JF796187.
and 546 (CT) from eleven strains and amino acid mutations in
two strains (Pro547Thr and Tyr573Phe). The Brazilian strains did
not show the mutation at position 440 (TA) that had been previ-
ously described (Calderón et al., 2011; Decaro et al., 2009; Hong
et al., 2007; Kapil et al., 2007). The CPV-2c was the main subtype
detected in the Brazilian samples, as previously found in the United
States (Honget al., 2007),Uruguay (Pérez et al., 2007) andArgentina
(Calderón et al., 2009). The detection of CPV-2c in Europe, Asia and
the Americas is an indication of the worldwide spread of this new
variant in thecaninepopulation (Decaroet al., 2006, 2007).Martella
et al. (2005) indicated an increasing replacement of subtypes
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PV-2a andCPV-2bbyCPV-2c that, from2000until 2004, increased
rom17% to60%of the samples in Italy. Pérez et al. (2007) suggested
hat the rapid spread of subtype 2c was likely associated with an
mportant nucleotide substitution and might lead to the elimina-
ion of the other subtypes of CPV-2 over time. In other countries,
uch as India (Raj et al., 2010), Belgium and Italy (Decaro et al.,
009), the predominance of the type 2a strains has been veriﬁed.
he CPV-2b has a more homogeneous distribution and has been
etected in different Brazilian regions and in other European coun-
ries, such as France and the UK (Decaro et al., 2009; Pereira et al.,
000).
Phylogenetic analysis of the variants circulating in the canine
opulation of some regions of Brazil has shown that they are very
imilar to those found in other countries and do not indicate a
ommon geographical origin and are thus termed cosmopolitan.
n contrast, mutations were detected in two amino acids (547 and
73) from sequences with the accession numbers JF796207 and
F796206, which were not reported in any other country.
The results of the present study demonstrate that 2c is the main
PV type that circulated in Brazil between the years 2008 and 2010,
ffecting puppies either with or without a complete vaccination
rotocol. Most of the positive samples, as identiﬁed by PCR, were
romdogswith signs of haemorrhagic gastroenteritis. Phylogenetic
nalysis of the variants circulating in the caninepopulationof Brazil
hows that they are very similar to those from other countries in
he Americas.
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